The latest report by IMARC Group titled, “Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2017-2022”, finds that the Brazil generic drug market reached a value of more than US$ 80 Billion in 2016, growing at a CAGR of around 15% during 2010-2016. In 1999, a law was passed by the government of Brazil – The Generic Drugs Law – which allowed the substitution of generic drugs for trademark branded drugs. This law authorized laboratories to handle and sell drugs, thereby enabling commercialisation and availability of previously more expensive branded drugs after the expiry of their patents. This has helped in improving the quality of drugs and facilitating the consumers to access quality drug treatment.
Request sample report - http://www.imarcgroup.com/request?type=report&id=696&flag=B
Highlights of Brazil generic drug market:
- The Generic Drugs Law gave impetus to the market and helped in improving the quality of the generic drugs.
- Free distribution of medicines for the treatment of various diseases by the government and public health system provide stimulus for the market growth.
- The factors such as increasing aging-population and growing lifestyle diseases have further driven the demand for generic drugs in the region.
Browse full report - http://www.imarcgroup.com/generic-drug-market-brazil
The report examines the competitive landscape of the market and provides the details of the major players of the market such as EMS S.A., Sanofi Group, Eurofarma Laboratórios S.A., Hypermarcas S.A., Sandoz, Ache Laboratories and União Química Farmacêutica Nacional S.A. The report also provides an in-depth analysis on the historical, current and future trends in the generic drug market in Brazil. This research report serves as an exceptional tool to understand the drivers, sales trends, volume trends, market structure, competitive landscape, regulations, key players, manufacturing and the outlook of generic drugs in Brazil. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Brazil.
Browse related reports on healthcare - http://www.imarcgroup.com/categories/healthcare-market-research-reports
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
USA: +1-631-791-1145
Email: [email protected]
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal